Clinical trials for cutaneous T-cell lymphoma (CTCL)
Cutaneous Lymphomas (T-cell and B-cell) and lymphoproliferative disorders
Graft vs Host Disease
Extracorporeal Photopheresis
Selected Publications
Asare C, Chen J, Ottevanger R, Scarisbrick J, Olsen EA, Tawa M, Thornton S, Kim E, Khan N, Larocca C, Shinohara MM. : Systematic literature review to identify patient-reported outcome measures for patients with cutaneous T-cell lymphoma.
International Dermatology Outcomes Measures 11th Annual Meeting, Washington D.C. April 2024.
Rastogi S, Kim EJ, Gelfand JM, Loren AW, Baumrin E: Chronic graft-versus-host disease-associated muscle cramps: severity and response to immunomodulatory therapies
Transplant Cell Ther 24, Jan 2024 Notes: doi: 10.1016/j.jtct.2023.12.674. Epub ahead of print.
Weiner DW, Rastogi S, Lewis DJ, Cohen L, Choi S, Vittorio CC, Haun PL, Samimi SS, Villasenor-Park J, Bhansali RS, Chong EA, Landsburg DJ, Nasta SD, Schuster, Svoboda J, Kim EJ, Rook AH, Barta SK.: Mogamulizumab Multimodality Therapy with Systemic Retinoids, Interferon, or Extracorporeal Photopheresis for Advanced Cutaneous T-Cell Lymphoma. Dermatologic Therapy Dec 2023 Notes: https://doi.org/10.1155/2023/7625926.
Bagot M, Kim YH, Geskin LJ, Ortiz-Romero P, Kim E, Mehta-Shah N, Dereure O, Oro S, Beylot-barry M, Dalle S, Jacobsen E, Lansigan F, Ram-Wolff C, Khodadoust MS, Battistella M, Gru A, Moins-Teisserenc H, Zinzani PL, Viott J, Paiva C, Muller M, Porcu P.: Lacutumab in Patients with Relapsed and Refractory Sezary Syndrome: Results from the Tellomak Phase 2 Trial. American Society of Hematology Annual Meeting, San Diego, CA Dec 2023.
Gunter S and Kim EJ: Impact of Guidelines from the 2011 International Society for Cutaneous Lymphomas on Registered and Pivotal Clinical Trials in Cutaneous T-Cell Lymphoma: A Retrospective Cohort Study. J Invest Dermatol 23: 3038-5. Nov 2023 Notes: doi: 10.1016/j.jid.2023.10.011. Epub ahead of print.
Polgione B, Alexander-Savino CV, Kim EJ, Mangold AR, Desimone J, Wong H, Rumage AT, Donini O, Haulenbeek A, Schaber CJ, Straube R, Pullion C, Rook AH.: HyBryte™ Use in Early-Stage Cutaneous T-cell Lymphoma
Front Drug Discov 3, Nov 2023.
Banbury S, Chu B, Hedberg L, Ogunleye TA, Kim E, Rosenbach M.: Four Cases of Cutaneous Rosai Dorfman in Black Patients: A Review of a Single Institution’s experience with this Rare Disease JAAD Case Rep
. 42: 117-121, Oct 2023 Notes: doi: 10.1016/j.jdcr.2023.09.032.
Hardin J, Cohen L, Rook AH, Kim EJ.: Evaluating Photopheresis Regimens for advanced CTCL: The role of the SARS COV2 pandemic, a single center retrospective study.
Dermatologic Therapy
2023: 9652322, Mar 2023 Notes: https://doi.org/10.1155/2023/9652322.
Chelius M, Cohen L, Jiang C, Mallon J, Greisz J, Tierney A, Hossain N, Rook A, Villasenor-Park J, Samimi S, Kim E, Plastaras JP, Barta SK, LaRiviere M.: Safety of Total Skin Electron Therapy with Concurrent Systemic Therapy
American Academy of Dermatology Annual Meeting, San Diego, CA Mar 2023.
Chairatchaneeboon M and Kim EJ: Parapsoriasis. Fitzpatrick's Therapeutics: a clinician's guide to dermatologic treatment. Kang S, Goh CL, Kim N, Kwatra S (eds.). McGraw-Hill LLC, 2023.
back to top
Last updated: 04/02/2024
The Trustees of the University of Pennsylvania